COMP <GO>
MCK vs CAH // DIVIDEND YIELD & FCF PAYOUT SAFETY
McKesson Corporation (NYSE) VS. Cardinal Health Inc. (NYSE) • 15-METRIC TALLY: MCK 11
— CAH 3
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: CAH
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
dividend-safety
0.33%
LAST: $250.48 (-0.24%) • MKT CAP: $58.14B
dividend-safety
0.85%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MCK VS. CAH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MCK | CAH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 3.70% | -0.10 | CAH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 38.60% | 29.70% | +8.90 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 24.5x | -5.00 | MCK | /valuation <GO> |
| Free Cash Flow Yield | 5.00% | 3.18% | +1.82 | MCK | /fcf-yield <GO> |
| Operating Margin | 1.50% | 1.00% | +0.50 | MCK | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 0.70% | +0.50 | MCK | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | -1.90% | +14.30 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.33% | 0.85% | -0.52 | CAH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.96 | 5.16 | +1.80 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | MCK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.1 | 59.1 | -3.00 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.90 | +0.05 | MCK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 34.6x | -14.40 | MCK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $114.36B | $58.14B | $56.22B | MCK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MCK REV | CAH REV | MCK GROSS % | CAH GROSS % | MCK FCF | CAH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $403.43B | $222.58B | 3.6% | 3.7% | $5.72B | $1.85B |
| FY 2024 | $359.05B | $226.83B | 3.7% | 3.3% | $5.55B | $3.25B |
| FY 2023 | $308.95B | $204.98B | — | — | -$9.59B | -$6.38B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MCK // BETA 0.95
CAH // BETA 0.90